Documente Academic
Documente Profesional
Documente Cultură
A
large and increasing number of patients use medicinal herbs or seek the advice of their
physician regarding their use. More than one third of Americans use herbs for health
purposes, yet patients (and physicians) often lack accurate information about the safety
and efficacy of herbal remedies. Burgeoning interest in medicinal herbs has increased
scientific scrutiny of their therapeutic potential and safety, thereby providing physicians with data to
help patients make wise decisions about their use. This article provides a review of the data on 12 of
the most commonly used herbs in the United States. In addition, we provide practical information
and guidelines for the judicious use of medicinal herbs. Arch Fam Med. 1998;7:523-536
More than one third of Americans use herbs • Your spouse has high cholesterol, your
for health purposes, spending over $3.5 bil- child has recurrent ear infections, and
lion annually.1,2 Yet patients (and physi- you have trouble relaxing after a hectic
cians) often lack accurate information about day at the clinic. Prompted by your pa-
the safety and efficacy of herbal remedies. tients’ questions, you wonder if any herbal
Imagine the following are patients in your remedies might benefit your family.
primary care practice. How would you ad- Popular use of medicinal herbs makes
vise them? it necessary for physicians to become aware
• Jane, who has chronic hepatitis C and of their health benefits, risks, and uncertain-
receives medicine for both hyperten- ties so that they can educate their patients
sion and schizophrenia, asks if she can about these issues. To assist clinicians in this
take milk thistle to protect her liver. task, this article reviews existing data on the
• John, who has the human immunode- history, safety, and efficacy of 12 of the most
ficiency virus, has an increasing viral commonly used and best-studied medicinal
load. He expresses fear of “medicine,” herbs (Table 1). In addition, it summarizes
but requests information about St John’s general information about herbal therapies,
wort (SJW) in hopes of “naturally” cur- including an overview of regulatory history
ing his human immunodeficiency vi- (Table 2), important similarities and dif-
rus and depression. ferences between medications approved by
• Sam’s wife bought him valerian to help the Food and Drug Administration (FDA)
him sleep, saw palmetto for his urinary and herbal therapies (Table 3), and the
difficulties, and gingko to improve his nature of available data about medicinal
memory. He is inclined to throw the herbs. Finally, lists of reliable introduc-
herbs away but wants your opinion. tory resources (Table 4) and guidelines
• After you inform Stephanie that she is 3 for patients (Table 5) are provided.
months pregnant, she asks what effects
the herbs she has taken for months will A HISTORICAL PERSPECTIVE
have on her fetus (ginger for nausea,
feverfew for headaches, and pen- Plants have been used medicinally through-
nyroyal to induce a period). out history. Through the first half of this cen-
From the Robert Wood Johnson Clinical Scholars Program, University of Washington
Health Sciences Center (Dr O’Hara), and the University of Washington Family This article is also available on our
Medicine Network, Swedish Family Medicine Residency (Drs Kiefer and Farrell),
Seattle; and the Center for Holistic Pediatric Education and Research, The Children’s
Web site: www.ama-assn.org/family.
Hospital, Boston, Mass (Dr Kemper).
*GRAS indicates generally recognized as safe; URI, upper respiratory infection; HIV, human immunodeficiency virus; tid, three times daily; GI, gastrointestinal;
bid, twice daily; LDL, low-density lipoprotein; TG, triglycerides; qd, every day; qid, four times daily; IV, intravenous; MAO, monoamine oxidase; PVR, post–void
residual; PSA, prostate-specific antigen; qhs, every night. See text for more information and references.
†Adapted from study reference system of the US Preventative Services Task Force (USPSTF), 1996, 2nd edition. Type of Evidence: I indicates randomized
controlled trial; II, other human study (1 = placebo-controlled trial, 2 = cohort or case-controlled study, 3 = case series); III, animal study (vs expert opinion in
USPSTF rating); IV, in vitro studies (not a category in USPSTF). Recommendation: A indicates safe and effective; B, probably safe and effective; C, probably safe,
possibly effective; D, insufficient data; and E, unsafe or ineffective.
‡Data are often lacking on drug interactions and effects of long-term use.
§Content and quality of commercial products are not regulated in the United States and can vary considerably.
\ Safety in pregnancy, lactation, and childhood is unknown (and use in these groups therefore not recommended) unless specifically indicated.
¶ Patients should use standardized preparations, which are more reliable and cost-effective.
**Range of costs for commercial products ($brands) in typical drug store.
††Generally recognized as safe as a food supplement by the FDA.
pies, aspirin from willow bark, and age. In addition, herbs may be con- ably the best compendium of clini-
tamoxifen from the Pacific yew tree.4 taminated or misidentified at any stage cal information about herbs in the
Unlike the FDA-approved over- from harvesting through packaging. world, it does not disclose the sci-
the-counter and prescription medi- entific basis for its conclusions. Nev-
cations, medicinal herbs are not THE NATURE OF EVIDENCE ertheless, such guidelines provide
required to demonstrate either safety ABOUT MEDICINAL HERBS hypotheses to prompt quality human
or efficacy prior to marketing, nor are trials, optimally with randomized,
they regulated for quality. Neverthe- Most research on medicinal herbs is double-blind, placebo-controlled
less, herbal therapies are not neces- conducted in areas of the world (RDBPC) trials. Research in the
sarily less expensive than patented where the use of medicinal herbs is United States will be bolstered by the
drugs and are rarely covered by medi- mainstream, particularly in Asia and creation of the Office of Comple-
cal insurance. In contrast to the pu- Europe. For the past 3 decades, the mentary and Alternative Medicine
rified, standardized, and potent FDA- German Health Authority has sys- within the National Institutes of
approved drugs, herbs contain an tematically reviewed the evidence on Health, Bethesda, Md.
array of chemicals, the relative con- about 300 herbs and formulated Data about the safety and efficacy
centration of which varies consider- clinical guidelines. An English trans- ofmedicinalherbsarelimitedinanum-
ably depending on genetics, grow- lation of the resulting German Com- berofways.Insomecases,thebestdata
ing conditions, plant parts used, time mission E Monographs is due for are years old, limited to in vitro or ani-
of harvesting, preparation, and stor- release in 1998.5 Although argu- mal studies, and/or only available in
*Select list of herbs most likely to be used by family medicine patients. Adapted from Tyler.2,4
along roadsides. The name stems cently approved encapsulated well as the months of use needed for
from the Latin febrifugia, “fever re- feverfew leaves as an over-the- clinical efficacy.25
ducer.” The first century Greek phy- counter medication for migraine In summary, some feverfew
sician Dioscorides prescribed fever- prophylaxis. However, migraines preparations can prevent mi-
few for “all hot inflammations.” Also were not prevented in a subse- graines, with efficacy that com-
known as “featherfew,” its feathery quent randomized controlled trial pares favorably with b-blockers and
leaves are used commonly to treat (RCT) using a different formula- valproic acid.31 However, side ef-
arthritis and prevent migraines.25 tion of feverfew (0.35% = 0.5 mg of fects may limit the use of feverfew,
While feverfew did not reduce symp- parthenolide, a suspected active in- as 5% to 15% of users develop aph-
toms in a double-blind, placebo- gredient).29 This highlights the po- thous ulcers and/or gastrointes-
controlled (DBPC) trial among pa- tential variability of contents and ef- tinal (GI) tract irritation.25 Sudden
tients with rheumatoid arthritis,26 it fects of different preparations of the discontinuation can precipitate re-
has been shown to prevent mi- same herb, as well as the inad- bound headaches.28 Long-term safety
graines in 2 of 3 DBPC trials. equacy of standardizing herbs to a data are lacking. Feverfew should
The largest and best DBPC trial single ingredient when other bioac- not be used during pregnancy (his-
was a crossover study in which fe- tive constituent(s) are not well char- torically it has been used to induce
verfew use was associated with a acterized. menstrual bleeding) or in patients
70% reduction in migraine fre- Laboratory evidence indicates with coagulation problems (fever-
quency and severity (n = 270).27 Side that feverfew causes vasodilation and few can alter platelet activity30). For
effects were less frequent than with reduces inflammation. Feverfew’s patients who want to try feverfew,
placebo. In a trial among feverfew constituents inhibit phagocytosis, expert herbalists recommend a
users, subjects randomized to re- platelet aggregation, and secretion of gradual dose increase up to 125 mg/d
ceive a placebo instead of continu- inflammatory mediators (arachidon- orally of encapsulated leaves (2-3
ing feverfew suffered a significant in- ic acid and serotonin).30 Feverfew is leaves) standardized to contain 0.2%
crease in the frequency and severity thought to down-regulate cerebro- parthenolide. However, according to
of headaches, nausea, and vomit- vascular response to biogenic a 1992 study, none of the commer-
ing (n = 20).28 Based on these tri- amines, consistent with its ability to cially available North American
als, Canadian health officials re- prevent but not abort headaches, as preparations contained even half of